Evidence review
Is NAD+ Really Anti-Aging?
The NAD+ anti-aging story rests on sirtuins and animal data. Here's what human trials do — and don't — show about NAD+ and aging.
"Anti-aging" is the boldest claim in the NAD+ category, and the one with the largest gap between marketing and evidence. The mechanism is genuinely interesting and grounded in decades of research. The human outcomes that would justify calling NAD+ an anti-aging therapy, however, mostly don't exist yet. This is a case where being honest about the limits is the whole point.
The mechanism: NAD+ and sirtuins
The anti-aging case is built on the sirtuins — a family of enzymes that depend on NAD+ to function and that regulate metabolism, stress resistance, and DNA repair. The foundational thesis is that declining NAD+ leads to reduced sirtuin activity, which in turn drives features of aging 12. It's a coherent and well-developed model. Crucially, though, this body of work is largely mechanistic and preclinical — built on cell and animal experiments, not human lifespan or healthspan outcomes 12. The mechanism explains *why* NAD+ restoration *might* slow aging; it does not demonstrate that it *does* in people.
The human outcomes are limited
When you look for human trials showing that NAD+ precursors actually reverse or slow aging, you find narrow, mixed, or null results rather than the dramatic effects implied by marketing.
Cognition is a telling test case, because cognitive decline is a core feature of aging. In a randomized placebo-controlled trial, nicotinamide riboside raised blood NAD+ about 2.6-fold in older adults with mild cognitive impairment — but neurocognitive measures were unchanged 3. The biomarker moved; the aging-relevant outcome did not. On the metabolic side, a systematic review and meta-analysis of NAD+ precursors found that clinical benefits on metabolic-syndrome parameters are limited and inconsistent despite reliably raised NAD+ 4. These are exactly the human "healthspan" outcomes you'd want an anti-aging therapy to move, and the precursors largely don't.
The confounded "positive" cognition trial
There is one frequently-cited human trial that looks encouraging: a phase-II study reporting improved cognitive function in Alzheimer's patients. But it tested a **combination** of metabolic activators — including nicotinamide alongside other ingredients — so any NAD+-specific contribution cannot be isolated 5. A multi-ingredient combo showing a signal is not evidence that NAD+ itself is the active anti-aging agent. It's a useful reminder to read past the headline and check what was actually administered.
Why animal results don't transfer cleanly
It's fair to ask why promising mouse data haven't translated. Part of the answer is that short-lived laboratory animals, kept in controlled conditions and often studied under metabolic stress or disease models, are a poor proxy for healthy, long-lived humans. Effects that look dramatic over a mouse's two-year life frequently shrink or vanish when tested in people over months. This is a recurring pattern across the longevity field, not a quirk of NAD+ — and it's exactly why the foundational reviews are careful to frame the human translation as early rather than established 12.
No human lifespan or aging-reversal evidence
The blunt summary: no human trial has shown that an NAD+ precursor extends lifespan, reverses aging, or even consistently improves the markers most associated with healthy aging. The lifespan-extension data live in model organisms; the human translation is, as the foundational reviews acknowledge, still early 1. That gap matters most when you encounter confident "reverse your biological age" marketing — there is no human trial result that earns that promise.
And there's no injectable/nasal anti-aging proof either
Clinics often market IV or nasal NAD+ specifically as anti-aging or "cellular rejuvenation." It bears repeating: **there is no rigorous human RCT of injectable, IV, or nasal NAD+** for aging or any other endpoint. The (limited) human anti-aging evidence that exists is from oral precursors and is unconvincing; for the non-oral routes, there is simply no controlled human evidence at all.
The cautious truth
Is NAD+ really anti-aging? Based on human evidence: not demonstrated. The mechanism — NAD+ fueling sirtuins — is real and compelling, and it justifies continued research 12. But the human outcomes are limited, the most-cited positive cognition result is confounded by other ingredients 5, and aging-relevant endpoints like cognition and metabolic health frequently fail to improve even when NAD+ rises 34. Treat "anti-aging" as a hypothesis under investigation, not a proven benefit you can buy.
For the full evidence picture across energy, focus, and longevity, see our pillar guide: NAD+ therapy: the evidence.
Frequently asked questions
Is NAD+ proven to be anti-aging?
No. The anti-aging case rests on the NAD+–sirtuin mechanism and on animal studies. No human trial has shown that an NAD+ precursor extends lifespan or reverses aging, and aging-relevant human outcomes like cognition and metabolic health often fail to improve even when NAD+ rises.
Doesn't one trial show cognitive benefits?
The frequently-cited positive trial tested a combination of metabolic activators including nicotinamide alongside other ingredients, so the NAD+-specific contribution can't be isolated. A dedicated NR trial in mild cognitive impairment raised NAD+ but did not improve cognition.
What about sirtuins and longevity?
Sirtuins depend on NAD+ and are central to the aging hypothesis, but that work is largely mechanistic and from cell and animal studies. It explains why NAD+ restoration might help, not that it does in humans.
Do IV or nasal NAD+ have anti-aging proof?
No. There is no rigorous human trial of injectable, IV, or nasal NAD+ for aging or any endpoint. Clinic marketing that calls these 'cellular rejuvenation' is not backed by controlled human evidence.
References
- Imai S, Guarente L (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology. https://pubmed.ncbi.nlm.nih.gov/24786309/
- Imai SI, Guarente L (2016). It takes two to tango: NAD+ and sirtuins in aging/longevity control. npj Aging and Mechanisms of Disease. https://pubmed.ncbi.nlm.nih.gov/28721271/
- Orr ME, Powers B (2024). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. https://pubmed.ncbi.nlm.nih.gov/37994989/
- Oliveira-Cruz A, et al. (2024). Effects of Supplementation with NAD+ Precursors on Metabolic Syndrome Parameters: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research. https://pubmed.ncbi.nlm.nih.gov/39111741/
- Yulug B, Mardinoglu A (2023). Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. Translational Neurodegeneration. https://pubmed.ncbi.nlm.nih.gov/36703196/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
NAD+ Therapy for Energy, Focus & Longevity: The Evidence
An honest, citation-backed look at what NAD+ therapy can and cannot do for energy, focus, and longevity — and where the evidence runs out.
ReadDoes NAD+ Actually Boost Energy?
NAD+ powers cellular energy metabolism — but does supplementing it make you feel more energetic? The honest answer from human trials.
ReadNMN vs NR: What the Human Trials Show
NMN and NR both raise NAD+ — but how do their human trials compare on insulin sensitivity, walking, sleep, cognition, and safety?
Read